• Accueil
  • Mediakit 🇫🇷 🇬🇧
    • Programme rédactionnel
    • Tarifs
    • Formats & infos techniques
    • Diffusion
  • Agenda
  • La Revue
  • L’équipe
  • Podcasts & vidéos
  • Derniers numéros
  • Linéaires
  • Alimentaire
  • Parfumerie & Cosmétique
  • Pharmacie
  • Industrie
    • Matériel
    • Matériaux
    • Emballages
  • News 🇬🇧
logo
  • Mediakit 🇫🇷 🇬🇧
    • Programme Rédactionnel
    • Tarifs
    • Formats & infos techniques
    • Diffusion
  • Agenda
  • La Revue
  • L’équipe
  • Podcasts & vidéos
  • Derniers numéros
S'abonner / subscribe linkedin
  • Accueil
  • Linéaires
  • Alimentaire
  • Parfumerie & Cosmétique
  • Pharmacie
  • Industrie
    • Matériel
    • Matériaux
    • Emballages
  • News 🇬🇧

Catalent increases specialized packaging capabilities at its Philadelphia facility

News 🇬🇧

Pharmacy

posted Wednesday 12 January 2022

Catalent announced that it has increased cold chain packaging capabilities at its Philadelphia facility to support increased demand for the distribution of biologic drugs, and advanced cell and gene therapies. Work has been undertaken at the facility to expand the packaging area by around 20,000 square feet and includes the addition of seven new temperature-controlled processing suites, which can operate at either refrigerated or frozen conditions to precisely match the needs of the drugs being handled. Further ambient space has also been added for packaging operations and materials storage.

The new suites include full serialization capabilities, specifically designed for small-scale batches of commercial products. Validation of the equipment is expected to be completed by the end of Q1 2022.

“Advanced therapeutics require increasingly complex handling requirements, and the investment we have made in Philadelphia allows Catalent to operate efficient packaging processes and operations, bridging the gap between clinical scale and niche commercial volumes,” commented Ann McMahon, General Manager of Commercial & Integrated Development Operations at Catalent Clinical Supply Services. “The specifically designed packaging areas not only provide optimal commercial opportunities for drug developers, but also the safest working conditions for employees in terms of air exchange rates, carbon dioxide monitoring, and ultraviolet air sanitization.”

The 200,000 square-foot Philadelphia facility is the largest site in Catalent’s global clinical supply network and the company’s North American Center of Excellence for clinical supply packaging. It includes an on-site pharmacy to support FlexDirect® direct-to-patient services for clinical trials, as well as access to Catalent’s FastChain® demand-led supply services, primary and secondary packaging capabilities, a range of temperature options for storage and distribution, and clinical returns and destruction services.

All rights reserved except agreement written by Emballage Digest or mention of the magazine

Article Précédent

Thermolabel tombe dans le giron de Barcodis

Article Suivant

Naissance d’un nouveau BTS en plasturgie cosmétique

Food

Packaging

Parfumerie & Cosmétique

Pharmacy

CCL Industries reprend Sleever International

posted Monday 16 March 2026

Matériaux

News 🇬🇧

MM Board & Paper expands MCM® Smart production to third European mill

posted Wednesday 11 March 2026

Food

News 🇬🇧

Packaging

Parfumerie & Cosmétique

Lindal acquires manufacturing facility in Wismar, Germany

posted Tuesday 10 March 2026

Linéaires

Machines

Packaging

Pharmacy

Bausch+Lomb améliore la production de ses dispositifs médicaux ophtalmiques stériles

posted Tuesday 10 March 2026

Abonnements

Trouvez l'abonnement qui vous convient

voir les offres
logo de Emballage Digest
  • Linéaires
  • Alimentaire
  • Parfumerie & Cosmétique
  • Pharmacie
  • Industrie
  • News 🇬🇧
  • Derniers numéros
  • L’équipe
  • Mediakit 🇫🇷 🇬🇧
  • La Revue
  • Agenda
  • Podcasts & vidéos
Mentions légales | Site conçu et réalisé par DEV INFLUENCE

© EMBALLAGE DIGEST - Tous droits réservés